Trials / Completed
CompletedNCT01737268
Long-term Study of FK949E in Elderly Bipolar Disorder Patients
Long-term Study of FK949E in Elderly Patients -Long-term Study in Elderly Bipolar Disorder Patients With Major Depressive Episodes-
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
FK949E was administered to elderly bipolar disorder patients with major depressive episode for 52 weeks. Its safety, efficacy, and plasma concentration change were evaluated in an open-label manner.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FK949E | Oral tablet |
Timeline
- Start date
- 2012-10-29
- Primary completion
- 2016-06-29
- Completion
- 2016-06-29
- First posted
- 2012-11-29
- Last updated
- 2024-11-19
- Results posted
- 2017-10-31
Locations
32 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01737268. Inclusion in this directory is not an endorsement.